Publications
34
Citations
247
Est. group size
~1
Recurring co-author estimate
Active years
12
Publishing since 2015
Tirisham Gyang's work focuses on multiple sclerosis (MS) and related autoimmune and inflammatory disorders of the nervous system, including neuromyelitis optica spectrum disorder and MOG-antibody disease. Their research spans clinical trials, disease prevalence and diagnosis, treatment safety (such as ocrelizumab and anti-CD19 therapies), and disparities in MS and stroke care across different racial and ethnic groups.
Publication output has been relatively steady over the past five years, averaging about 3-4 papers per year after a peak of 8 in 2020, without a clear increasing or decreasing trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Focal Motor Seizures as a Manifestation of Rheumatoid Meningitis
Neurology Neuroimmunology & Neuroinflammation · 2026
- The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants
Contemporary Clinical Trials · 2025
- ANTI-CD19 MONOCLONAL ANTIBODY FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND NEUROMYELITIS OPTICA SPECTRUM DISORDER
Lupus Science & Medicine · 2025
- Differential diagnosis of suspected multiple sclerosis: global health considerations
The Lancet Neurology · 2024
- Abstract HUP13: Assessing Patient Perceptions Of Strokes Reveals Limited Coherence And Perceived Barriers To Treatment Compliance In Hospitalized Stroke Patients Independent Of Race/ethnic And Socioeconomic Factors
Stroke · 2023
- Making Sure Multiple Sclerosis Counts and Is Counted for All—An Update on Multiple Sclerosis Prevalence by Race and Ethnicity in the United States
JAMA Neurology · 2023
- Anti-NMDA Receptor Encephalitis Related to Renal Cell Carcinoma: A Case Report
The Neurohospitalist · 2023
- The Importance of Incorporating Stroke Survivors’ Health Perceptions in Addressing Health Care Disparities
Ethnicity & Disease · 2022
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Transverse Myelitis Probably Associated With SARS-CoV-2 mRNA Vaccines: Two Case Reports
The Neurohospitalist · 2022
- Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse population
Multiple Sclerosis and Related Disorders · 2022
- COVID-19 mRNA vaccines associated with MOG-Ab disease and transverse myelitis: Two case reports (P11-4.009)
Neurology · 2022
- Treatment of Adult Onset Rasmussen’s Encephalitis with Tocilizumab (4952)
Neurology · 2021
- Abstract P880: Assessing Measures of Patients Health Perceptions of Stroke Survivors as a Potential Tool for Health Care Disparities Research
Stroke · 2021
- Anti-MOG associated disorder–Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD–A single-center experience
Multiple Sclerosis and Related Disorders · 2020
- Movement for multiple sclerosis: a multi-site partnership for practice and research
Arts & Health · 2020
- Neurology×13
- Multiple Sclerosis and Related Disorders×2
- Multiple Sclerosis Journal - Experimental Translational and Clinical×2
- The Neurohospitalist×2
- Stroke×2
- Qiuming Zeng
Medicine · The Ohio State University
- Yuji Tomizawa
Medicine · The Ohio State University
- Michael K. Racke
Medicine · The Ohio State University
- Christina N. Rau
Medicine · The Ohio State University
- Bennis Pavisian
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile